great
attent
paid
mechan
viru
entri
due
potenti
role
develop
novel
therapeut
vaccin
virus
often
take
advantag
multipl
endocyt
pathway
enter
cell
clathrinmedi
endocytosi
best
character
pathway
exploit
mani
virus
human
immunodefici
viru
hiv
hepat
c
viru
hcv
rabi
viru
astroviru
frog
viru
apart
clathrinmedi
entri
caveoladepend
endocytosi
altern
well
character
pathway
viru
entri
compar
clathrin
intern
caveola
slower
result
vesicl
becom
acidifi
current
caveoladepend
endocytosi
known
exploit
sever
virus
includ
simian
viru
sv
tiger
frog
viru
tfv
echoviru
hepat
b
viru
hbv
addit
macropinocytosi
emerg
major
endocyt
mechan
cell
entri
anim
virus
varieti
virus
includ
envelop
nonenvelop
virus
adenoviru
picornaviru
viru
famili
well
vaccinia
viru
take
advantag
macropinocytosi
uptak
inhibitor
nah
exchang
amilorid
ethylisopropyl
amilorid
eipa
use
main
diagnost
test
clarifi
macropinocytosi
inhibitor
sever
cellular
factor
signal
pathway
also
inhibit
macropinocytosi
initi
differ
virus
ranavirus
nucleoplasm
larg
dna
virus
caus
major
econom
loss
aquacultur
industri
contribut
global
ecolog
instabl
genu
ranaviru
first
iridoviru
entri
mechan
investig
mammalian
cell
envelop
particl
intern
adsorpt
endocytosi
via
coat
pit
move
endosom
final
lysosom
suggest
entri
via
receptormedi
clathrin
endocytosi
contrast
recent
studi
demonstr
differ
mechan
use
differ
iridovirus
tfv
infecti
spleen
kidney
necrosi
viru
isknv
enter
differ
cell
via
caveoladepend
clathrindepend
endocytosi
singapor
grouper
iridoviru
sgiv
entri
host
cell
occur
via
clathrinmedi
endocytosi
macropinocytosi
phdepend
manner
differ
endocyt
pathway
use
variou
iridovirus
impli
complex
process
earli
step
iridoviru
infect
softshel
turtl
iridoviru
stiv
isol
diseas
softshel
turtl
trionyx
sinensi
complet
genom
sequenc
analysi
indic
stiv
like
differ
strain
viral
speci
belong
ranaviru
genu
vitro
stiv
infect
induc
typic
apoptosi
evok
mitogenactiv
protein
kinas
mapk
signal
pathway
moreov
fluorescencetag
recombin
stiv
enhanc
green
fluoresc
protein
egfp
stiv
success
construct
studi
infect
dynam
evalu
viral
replic
although
genom
sequenc
tfv
share
high
ident
endocyt
pathway
use
differ
complet
whether
entri
pathway
stiv
differ
report
ranaviru
isol
remain
unknown
demonstr
underli
cellular
entri
mechan
stiv
use
egfpstiv
result
shed
new
light
earli
event
iridoviru
infect
lower
vertebr
fhm
cell
cultur
medium
gibco
contain
fetal
bovin
serum
fb
gibco
green
fluoresc
proteintag
recombin
viru
egfpstiv
construct
previou
studi
express
egfp
fuse
membran
protein
natur
promot
egfpstiv
propag
fhm
cell
chlorpromazin
cpz
inhibitor
clathrinmedi
endocytosi
dynasor
specif
inhibitor
dynamin
cholesterol
synthesi
inhibitor
nystatin
lipid
raft
inhibitor
eipa
inhibitor
nah
channel
chloroquin
cq
bafilomycin
baf
specif
inhibitor
vacuolar
proton
atpas
purchas
sigmaaldrich
cytotox
chemic
regent
fhm
cell
determin
trypan
blue
exclus
test
describ
previous
fhm
cell
treat
drug
differ
concentr
collect
trypsin
incub
trypan
solut
sigma
min
experi
carri
triplic
dead
cell
count
three
independ
hemocytomet
count
cell
viabil
calcul
percentag
live
cell
total
number
cell
drug
concentr
use
studi
nontox
cell
viabil
fhm
cell
data
shown
h
pi
egfpstivinfect
cell
moi
fix
paraformaldehyd
wash
twice
phosphatebuff
salin
pb
green
fluoresc
indic
viru
entri
newli
synthes
viru
imag
use
fluoresc
microscop
leica
analyz
la
softwar
experi
imag
analysi
perform
three
time
imag
repres
result
three
replic
experi
flow
cytometri
analysi
mock
inhibitortr
cell
incub
egfpstiv
moi
h
cell
wash
pb
incub
trypsin
invitrogen
min
cell
transfer
centrifug
tube
centrifug
min
sampl
incub
paraformaldehyd
min
prior
resuspens
pb
flow
analysi
use
facscan
flow
cytomet
cellquest
softwar
bd
bioscienc
harvest
cell
lyse
icecold
report
lysi
buffer
lysat
centrifug
min
fluoresc
intens
gfp
supernat
measur
use
victor
multilabel
plate
reader
perkinelm
excit
wavelength
nm
emiss
wavelength
nm
autofluoresc
uninfect
lysat
detect
background
subtract
measur
egfpstivinfect
lysat
cell
harvest
lyse
cell
lysi
buffer
promega
protein
concentr
measur
use
bradford
protein
assay
kit
cell
lysat
fraction
sdspage
transfer
polyvinyliden
fluorid
membran
min
separ
protein
react
antimcp
major
capsid
protein
primari
antibodi
dilut
secondari
antibodi
horseradishperoxidaseconjug
goat
antimous
antibodi
dilut
intern
control
reaction
detect
carri
simultan
immunoblot
visual
use
enhanc
chemiluminesc
detect
system
amersham
ecl
western
blot
detect
kit
data
obtain
three
independ
experi
certain
agent
cpz
sucros
prevent
recycl
clathrin
plasma
membran
inhibit
clathrinmedi
endocytosi
elucid
mechan
underli
endocytosi
involv
stiv
entri
examin
role
clathrinmedi
endocytosi
use
cpz
sucros
fluoresc
microscopi
reveal
obviou
reduct
green
fluoresc
label
cell
treatment
cpz
mm
sucros
comparison
mocktreat
cell
fig
quantit
analysi
show
fluoresc
intens
cpz
sucrosetr
cell
significantli
reduc
dose
depend
manner
treatment
cpz
sucros
mm
decreas
fluoresc
intens
respect
compar
mocktreat
cell
fig
consist
flow
cytometri
show
percentag
fluorescencelabel
cell
significantli
reduc
treatment
cpz
sucros
fig
addit
protein
express
egfpstiv
mcp
evalu
use
western
blot
protein
synthesi
mcp
obvious
reduc
treatment
cpz
mm
sucros
fig
result
show
clathrinmedi
endocytosi
involv
stiv
entri
caveolamedi
viru
entri
inhibit
sterolbind
drug
nystatin
filipin
iii
investig
role
lipid
raftcaveolin
stiv
entri
use
sterolbind
drug
filipin
nystatin
impair
caveola
format
also
use
remov
cholesterol
cultur
cell
obvious
decreas
number
fluoresc
cell
compar
mock
treat
cell
contrast
number
fluoresc
cell
remain
almost
unchang
treatment
filipin
nystatin
fig
quantit
analysi
indic
fluoresc
intens
cell
significantli
decreas
dose
depend
manner
treatment
mm
decreas
fluoresc
intens
compar
mocktreat
cell
fig
flow
cytometri
also
confirm
percentag
fluorescencelabel
cell
significantli
reduc
treatment
fig
addit
protein
synthesi
inhibit
treatment
nystatin
filipin
iii
fig
togeth
result
suggest
stiv
entri
mediat
noncaveola
cholesteroldepend
pathway
defin
whether
macropinocytosi
involv
stiv
entri
eipa
nah
exchang
inhibitor
direct
highli
select
inhibitor
use
pretreat
fhm
cell
treatment
eipa
obvious
reduc
number
cell
label
green
fluoresc
fig
quantit
analysi
indic
fluoresc
intens
eipa
cell
significantli
reduc
dose
depend
manner
treatment
eipa
decreas
fluoresc
intens
compar
mocktreat
cell
respect
fig
consist
flow
cytometri
show
percentag
fluorescencelabel
cell
significantli
decreas
dosedepend
manner
treatment
eipa
fig
addit
protein
synthesi
mcp
also
significantli
inhibit
addit
eipa
fig
suggest
stiv
util
macropinocytosi
altern
pathway
enter
cell
increas
number
studi
report
variou
cellular
factor
involv
viru
entri
studi
regul
myosin
ii
activ
phosphoryl
myosin
light
chain
inhibit
activ
specif
inhibit
also
use
genistein
dynasor
cytochalasin
inhibit
tyrosin
kinas
larg
gtpase
dynamin
actin
polymer
gs
cell
respect
except
data
shown
fluoresc
intens
cell
treat
cytochalasin
cytod
dynasor
genistein
significantli
reduc
dose
depend
manner
treatment
cytod
dynasor
genistein
decreas
fluoresc
intens
respect
comparison
mocktreat
cell
fig
flow
cytometri
analysi
show
percentag
fluorescencelabel
cell
treatment
four
inhibitor
significantli
reduc
compar
mocktreat
cell
fig
also
evalu
effect
dynasor
viral
protein
synthesi
protein
synthesi
mcp
dynasor
cell
obvious
reduc
egfpstiv
infect
compar
seen
mocktreat
cell
fig
result
suggest
multipl
cellular
factor
signal
event
includ
myosin
ii
tyrosin
kinas
dynamin
actin
polymer
essenti
stiv
entri
assess
whether
stiv
entri
ph
depend
alter
endosom
acidif
cq
lysosomotrop
agent
baf
specif
inhibitor
endosom
protonatp
pump
green
fluoresc
cell
treatment
cq
baf
obvious
reduc
comparison
seen
mocktreat
cell
fig
quantit
analysi
show
fluoresc
intens
cq
baftreat
cell
significantli
reduc
dose
depend
manner
treatment
baf
cq
decreas
fluoresc
intens
respect
comparison
mocktreat
cell
fig
consist
flow
cytometri
anlaysi
indic
percentag
fluorescencelabel
cell
significantli
decreas
dosedepend
manner
treatment
cq
baf
fig
western
blot
show
protein
synthesi
mcp
significantli
inhibit
cq
baf
fig
thu
propos
stiv
enter
fhm
cell
phdepend
manner
virus
evolv
exploit
endocytosi
effect
mean
enter
host
cell
transport
site
suitabl
replic
therefor
explor
virusentri
mechan
might
provid
new
clue
develop
effect
drug
block
viru
infect
larg
dna
virus
iridovirus
attract
much
attent
impact
ecolog
instabl
role
heavi
econom
loss
aquacultur
industri
although
rapid
progress
made
field
iridoviru
function
genom
earli
event
iridoviru
infect
especi
viru
entri
still
unknown
clathrinmedi
endocytosi
wellcharacter
endocyt
pathway
exploit
number
virus
enter
host
cell
cpz
known
caus
clathrin
lattic
assembl
endosom
membran
time
prevent
assembl
coat
pit
plasma
membran
treatment
cpz
cellular
entri
mani
virus
includ
hiv
hcv
african
swine
fever
viru
asfv
hbv
rabi
viru
significantli
inhibit
suggest
clathrinmedi
endocytosi
involv
entri
process
virus
studi
percentag
fluoresc
indic
egfpstivinfect
cell
protein
synthesi
major
capsid
protein
significantli
decreas
treatment
cpz
anoth
inhibitor
clathrindepend
endocytosi
hyperosmot
sucros
prevent
clathrin
adaptor
interact
result
show
treatment
hyperosmot
sucros
also
decreas
viru
entri
similar
cpz
number
stivinfect
cell
significantli
inhibit
well
protein
synthesi
mcp
treatment
cq
baf
known
prevent
endosom
acidif
entri
stiv
fhm
cell
significantli
decreas
dynasor
inhibitor
gtpase
dynamin
requir
clathrinmedi
endocytosi
propos
stiv
enter
host
cell
clathrinmedi
endocytosi
phdepend
manner
notabl
clathrinmedi
endocytosi
also
report
crucial
tfv
entri
although
differ
strain
speci
propos
entri
mechan
virus
investig
differ
cell
type
whether
clathrinmedi
endocytosi
involv
tfv
infect
fish
frog
cell
need
investig
contrast
clathrinmedi
endocytosi
caveoladepend
endocytosi
newli
character
endocytosi
pathway
defin
movement
caveolin
caveoladeriv
vesicl
multipl
compart
cytoplasm
sterolbind
reagent
filipin
iii
nystatin
usual
use
impair
caveolamedi
endocytosi
due
high
abund
cholesterol
sphingolipid
caveola
treatment
filipin
iii
nystatin
decreas
cellular
entri
virus
includ
coronaviru
tfv
isknv
suggest
virus
use
caveoladepend
endocytosi
life
cycl
experi
treatment
decreas
percentag
stivinfect
cell
dosedepend
manner
neither
nystatin
filipin
iii
show
obviou
effect
stiv
entri
phenomenon
also
describ
sever
acut
respiratori
syndrom
coronaviru
infect
given
cholesterol
deplet
inhibit
format
bud
clathrinco
pit
propos
inhibit
stiv
entri
interf
caveoladepend
endocytosi
like
affect
integr
membran
lipid
microdomain
inhibit
clathrinmedi
endocytosi
although
numer
report
mani
virus
enter
cell
via
clathrindepend
caveolalipid
raftmedi
endocytosi
increas
attent
recent
paid
macropinocytosi
due
critic
role
viru
entri
eipa
specif
inhibitor
nah
exchang
critic
macropinosom
format
usual
use
evalu
impact
macropinocytosi
viru
entri
treatment
eipa
impair
entri
mani
mammalian
virus
includ
ebov
asfv
vaccinia
viru
human
cytomegaloviru
suggest
macropinocytosi
involv
entri
virus
ascertain
whether
macropinocytosi
altern
rout
stiv
entri
effect
eipa
stiv
infect
determin
stivinfect
cell
treatment
eipa
inhibit
viru
entri
protein
synthesi
dosedepend
manner
recent
studi
also
demonstr
sever
cell
factor
critic
macropinocytosi
viru
entri
inhibit
myosin
ii
activ
decreas
entri
asfv
influenza
viru
show
cellular
factor
import
macropinocyt
uptak
furthermor
inhibit
actin
polymer
cytod
decreas
cellular
entri
kaposi
sarcomaassoci
herpesviru
vaccinia
viru
asfv
suggest
actin
polymer
import
macropinocyt
pathway
studi
inhibit
activ
inhibit
myosin
ii
activ
significantli
prevent
stiv
entri
treatment
cyto
also
significantli
block
stiv
infect
therefor
conclud
stiv
enter
cell
via
macropinocytosi
notabl
macropinocytosi
specif
inhibitor
eipa
use
previou
studi
cellular
entri
tfv
inknv
disrupt
actin
microfila
cytochalasin
b
significantli
inhibit
tfv
entri
suggest
macropinocytosi
also
involv
tfv
entri
recent
studi
reveal
sgiv
enter
host
cell
via
clathrinmedi
endocytosi
macropinocytosi
phdepend
manner
propos
macropinocytosi
novel
altern
pathway
exploit
iridoviru
enter
cell
conclus
result
reveal
stiv
enter
cell
via
clathrinmedi
endocytosi
macropinocytosi
phdepend
manner
accord
previou
studi
propos
ranavirus
includ
stiv
sgiv
could
use
clathrinmedi
endocytosi
micropinocytosi
enter
cell
although
conclus
verifi
tfv
infect
fish
cell
frog
cell
interestingli
caveolamedi
endocytosi
involv
stiv
sgiv
entri
vitro
crucial
entri
tfv
cell
isknv
fish
fri
cell
fig
togeth
iridovirus
might
use
multipl
endocyt
pathway
entri
like
mammalian
virus
studi
provid
new
insight
understand
earli
event
iridoviru
pathogenesi
